- Home
- WOLF vs IMNM Comparison
WOLF vs IMNM Comparison
Compare WOLF & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- IMNM
- Stock Information
- Founded
- WOLF 1987
- IMNM 2006
- Country
- WOLF United States
- IMNM United States
- Employees
- WOLF N/A
- IMNM N/A
- Industry
- WOLF Semiconductors
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- WOLF Technology
- IMNM Health Care
- Exchange
- WOLF Nasdaq
- IMNM Nasdaq
- Market Cap
- WOLF 843.2M
- IMNM 806.1M
- IPO Year
- WOLF 1993
- IMNM 2020
- Fundamental
- Price
- WOLF $6.84
- IMNM $9.52
- Analyst Decision
- WOLF Hold
- IMNM Strong Buy
- Analyst Count
- WOLF 16
- IMNM 5
- Target Price
- WOLF $14.86
- IMNM $28.60
- AVG Volume (30 Days)
- WOLF 18.8M
- IMNM 1.2M
- Earning Date
- WOLF 01-29-2025
- IMNM 03-27-2025
- Dividend Yield
- WOLF N/A
- IMNM N/A
- EPS Growth
- WOLF N/A
- IMNM N/A
- EPS
- WOLF N/A
- IMNM N/A
- Revenue
- WOLF $776,600,000.00
- IMNM $10,129,000.00
- Revenue This Year
- WOLF N/A
- IMNM N/A
- Revenue Next Year
- WOLF $28.15
- IMNM N/A
- P/E Ratio
- WOLF N/A
- IMNM N/A
- Revenue Growth
- WOLF N/A
- IMNM N/A
- 52 Week Low
- WOLF $4.66
- IMNM $8.97
- 52 Week High
- WOLF $30.86
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- WOLF 55.11
- IMNM 40.66
- Support Level
- WOLF $4.92
- IMNM $9.67
- Resistance Level
- WOLF $7.67
- IMNM $10.68
- Average True Range (ATR)
- WOLF 0.55
- IMNM 0.80
- MACD
- WOLF 0.24
- IMNM -0.08
- Stochastic Oscillator
- WOLF 69.64
- IMNM 0.34
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.